BLAYO; Anne-Laure

Patent Applications and Registrations

Patent applications and USPTO patent grants for BLAYO; Anne-Laure.The latest application filed is for "substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4".

Company Profile

1.8.9

BLAYO; Anne-Laure - Souffelweyersheim FR
BLAYO; Anne-Laure - Credin FR
Blayo; Anne-Laure - Jupiter FL US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Quinazolinone Derivatives And Their Use As Positive Allosteric Modulators Of Mglur4 App 20220089609 - AMALRIC; Camille ; et al.	2022-03-24
5-azaindazole Derivatives As Adenosine Receptor Antagonists App 20210380606 - BLAYO; Anne-Laure ; et al.	2021-12-09
5-azaindazole Derivatives As Adenosine Receptor Antagonists App 20210361669 - BLAYO; Anne-Laure ; et al.	2021-11-25
Substituted Heterocyclic Compounds As Allosteric Modulators Of Group Ii Metabotropic Glutamate Receptors App 20200140438 - BLAYO; Anne-Laure ; et al.	2020-05-07
Modulators of the nuclear hormone receptor ROR Grant 9,586,928 - Kamenecka , et al. March 7, 2	2017-03-07
N-benzylindole modulators of PPARG Grant 9,051,265 - Kamenecka , et al. June 9, 2	2015-06-09
N-biphenylmethylindole modulators of PPARG Grant 8,957,093 - Kamenecka , et al. February 17, 2	2015-02-17
Modulators Of The Nuclear Hormone Receptor Ror App 20140187554 - Kamenecka; Theodore Mark ; et al.	2014-07-03
Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors Grant 8,546,435 - Aicher , et al. October 1, 2	2013-10-01
N-biphenylmethylindole Modulators Of Pparg App 20120309757 - Kamenecka; Theodore Mark ; et al.	2012-12-06
N-benzylindole Modulators Of Pparg App 20120309769 - Kamenecka; Theodore Mark ; et al.	2012-12-06
Novel Triazole Derivatives With Improved Receptor Activity And Bioavailability Properties As Ghrelin Antagonists Of Growth Hormone Secretagogue Receptors App 20120083494 - Aicher; Babette ; et al.	2012-04-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.